Methods of extending corneal graft survival

Details for Australian Patent Application No. 2003215337 (hide)

Owner Allergan, Inc.

Inventors De Vries, Gerlad W

Agent Davies Collison Cave

Pub. Number AU-B-2003215337

PCT Number PCT/US03/05125

PCT Pub. Number WO2003/072029

Priority 10/081,126 22.02.02 US

Filing date 20 February 2003

Wipo publication date 9 September 2003

Acceptance publication date 14 August 2008

International Classifications

A61K 45/00 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

A61K 31/00 (2006.01)

A61K 31/404 (2006.01)

A61K 31/7088 (2006.01) - Compounds having three or more nucleosides or nucleotides

A61K 31/7105 (2006.01) - Natural ribonucleic acids, i.e. containing only riboses attached to adenine, guanine, cytosine or uracil and having 3'-5' phosphodiester links

A61K 35/12 (2006.01) Medicinal preparations containing material or reaction products thereof with undetermined constitution - Materials from mammals or birds

A61K 38/17 (2006.01) Medicinal preparations containing peptides - from animals

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

A61K 45/06 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

A61K 48/00 (2006.01) Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases

A61P 9/00 (2006.01) Drugs for disorders of the cardiovascular system

A61P 27/02 (2006.01) Drugs for disorders of the senses

A61P 37/06 (2006.01) Drugs for immunological or allergic disorders

A61P 43/00 (2006.01) Drugs for specific purposes, not provided for in groups

Event Publications

31 July 2003 Complete Application Filed

  Priority application(s): 10/081,126 22.02.02 US

16 October 2003 Application Open to Public Inspection

  Published as AU-B-2003215337

14 August 2008 Application Accepted

  Published as AU-B-2003215337

11 December 2008 Standard Patent Sealed

17 September 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003215338-MOBILE PHASE TREATMENT FOR CHROMATOGRAPHY

2003215336-Compositions and formulations of 9- nitrocamptothecin polymorphs and methods of use thereof